Cancer, Survivorship
Conditions
Keywords
Chinese, Quality of Life, Patients, Survivors, 26-025
Brief summary
The purpose of this study is to evaluate different combinations of cancer education sessions, counseling sessions, and peer support meetings developed for Chinese cancer patients and survivors. The researchers will look at whether the combinations are practical and effective, and how they impact participants' quality of life.
Interventions
OTHERCancer Education
Cancer Education on side effects and their management, treatment options, advance care planning, and survivorship. Each session will last about 30-60 minutes and will be completed over the phone or by video call.
OTHERMeaning-Centered Counseling
Meaning-centered counseling aims to activate culturally relevant meaning-focused coping strategies in Chinese-speaking patients and survivors (CCS). Each session will last about 45-60 minutes and will be completed over the phone or by video call.
OTHERPeer Support
Peer support aims to increase social support for CCS to decrease cancer stigma, which has been associated with greater psychological distress, especially among less acculturated Chinese immigrant CCS. The meetings will include up to 6-8 Mandarin-speaking patients and survivors and will last about 90 minutes.
enhanced standard care ( written cancer information materials in Chinese and referral to counseling)
Sponsors
Memorial Sloan Kettering Cancer Center
American Cancer Society, Inc.
Brooklyn College Cancer Center
Herald Cancer Association
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
Using a 2x2x2 factorial design. Participants will be randomized to receive a combination of one or more culturally tailored telehealth-delivered intervention components.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosed with cancer (any type/stage) (per EMR for MSK patients or self-report for external participants) within the last 5 years * Age ≥ 18 years (per EMR for MSK patients or self-report for external participants) Self-Report Criteria: * Of Chinese descent * Speaks Mandarin "well" or "very well" * Moderately low HRQOL (\<70 FACT-G score)4, 48 * Resides in New York or New Jersey * Agrees to participate via telehealth (video or phone) * Agrees to be audio-recorded
Exclusion criteria
Self-Report Criteria: * Per PI determination, requires a higher level of care for current passive or active suicidal ideation than current protocol is able to provide. If a participant receives a score of \> 0 on item 9 of the PHQ-9,5 they will be referred to study PI for further evaluation using the Columbia-Suicide Severity Rating Scale. They will be excluded from participation in this study if there is presence of suicidal risk, determined by affirmative response(s) on the Columbia-Suicide Severity Rating Scale (C-SSRS) * Too ill to participate determined by the question: "Do you feel too ill to participate because of communication problems, uncontrollable pain, or other symptoms that prevent you from participating?" * Cognitive impairment (Montreal Cognitive Assessment 5 Minute - telephone version with a score \< 12) * Per consenting professional determination, unable to understand the informed consent procedure * Participation in study #14-076: Adaptation of Individual Meaning-Centered Psychotherapy for Chinese immigrant cancer patients) * Currently receiving/have received psychotherapy/counseling/peer support within the last 6 months (patients being treated solely with psychotropic medications will not be excluded if they are not receiving psychotherapy/counseling/peer support)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of eligible participants who enroll in the trial. | 2 years | — |
| Proportion of participants who complete treatment | 24 weeks | Pproportion of assessments that are completed, with completion defined as submitting the 24-week assessment with a minimum of the FACT-G completed. |
Countries
United States
Contacts
CONTACTFlorence Lui, PhD
CONTACTJennifer Leng, MD, MPH
PRINCIPAL_INVESTIGATORFlorence Lui, PhD
Memorial Sloan Kettering Cancer Center
Outcome results
None listed